From: Herpesvirus and neurological manifestations in patients with severe coronavirus disease
Virus | Central nervous system | p | Peripheral nervous system | p | Total | ||
---|---|---|---|---|---|---|---|
Yes N (%) | No N (%) | Yes N (%) | No N (%) | ||||
HSV-1 | |||||||
Yes | 3 (33.3) | 6 (66.8) | 0.684a | 2 (22.2) | 7 (77.8) | 0.129a | 9 (100) |
No | 11 (25) | 33 (75) | 2 (4.5) | 42 (95.5) | 44 (100) | ||
HSV-2 | |||||||
Yes | 1 (100) | 0 (0) | 0.264a | 0 (0) | 1 (100) | 0.999a | 1 (100) |
No | 13 (25) | 39 (75) | 4 (7.7) | 48 (92.3) | 52 (100) | ||
EBV | |||||||
Yes | 5 (33.3) | 10 (66.7) | 0.504a | 0 (0) | 15 (100) | 0.568a | 15 (100) |
No | 9 (23.7) | 29 (76.3) | 4 (10.5) | 34 (89.5) | 38 (100) | ||
CMV | |||||||
Yes | 9 (39.1) | 14 (60.9) | 0.066b | 0 (0) | 23 (100) | 0.124a | 23 (100) |
No | 5 (16.7) | 25 (83.3) | 4 (13.3) | 26 (86.7) | 30 (100) | ||
VZV | |||||||
Yes | 2 (50) | 2 (50) | 0.282a | 0 (0) | 4 (100) | 0.999a | 4 (100) |
No | 12 (24.5) | 37 (75.5) | 4 (8.2) | 45 (91.8) | 49 (100) | ||
HHV-6 | |||||||
Yes | 10 (40) | 15 (60) | 0.034b* | 0 (0) | 25 (100) | 0.113 a | 25 (100) |
No | 4 (14.3) | 24 (85.7) | 4 (14.3) | 24 (85.7) | 28 (100) | ||
HHV-7 | |||||||
Yes | 8 (38.1) | 13 (61.9) | 0.118b | 1 (4.8) | 20 (95.2) | 0.999a | 21 (100) |
No | 6 (18.8) | 26 (81.2) | 3 (9.4) | 29 (90.6) | 32 (100) | ||
HHV-8 | |||||||
Yes | 3 (33.3) | 6 (66.7) | 0.684b | 0 (0) | 9 (100) | 0.999a | 9 (100) |
No | 11 (25.0) | 33 (75.0) | 4 (9.1) | 40 (90.9) | 44 (100) |